A Meta-Analysis for Association of ACE I/D and PAI-1 4G/5G Polymorphisms with Recurrent Pregnancy Loss in Iranian Women: are the investigations adequate?Seyed Alireza Dastgheib1, Mojgan Karimi-Zarchi2, Reza Bahrami3, Razie Sadat Tabatabaei4, Atiyeh Javaheri5, Mahmood Noorishadkam5, Seyed Reza Mirjalili5, Hossein Neamatzadeh61Department of Medical Genetics, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran 2Neonatal Research Center, Shiraz University of Medical Sciences, Shiraz, Iran 3Department of Obstetrics and Gynecology, Firoozgar Hospital, Iran University of Medical Sciences, Tehran, Iran 4Department of Obstetrics and Gynecology, Shahid Sadoughi University of Medical Sciences, Yazd, Iran 5Mother and Newborn Health Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran 6Department of Medical Genetics, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
Objective: The associations of ACE I/D and PAI-1 4G/5G polymorphisms with recurrent pregnancy loss (RPL) in Iranian women have yielded controversial results. Thus, we carried out a meta-analysis to get more confidential results. Methods: A comprehensive literature search was carried out in PubMed, Web of Sciences, Scopus, MedRxiv, SID and CNKI databases up to 01 January, 2021 using the appropriate terms. All case-control studies were included. Odds ratios (ORs) and 95% confidence intervals (CIs) were used to estimate the strength of associations. Results: A total of 14 studies including eight studies with 783 cases and 761 healthy subjects on ACE I/D and six studies with 1,155 cases and 699 healthy subjects on PAI-1 4G/5G were included. Combined data revealed that ACE I/D polymorphism was significantly associated with RPL risk in Iranian women under three models i.e., allele (OR = 0.744, 95% CI: 0.640-0.864, P ≤0.001), dominant (OR = 0.774, 95% CI: 0.601-0.996, P =0.047), and recessive (OR = 0.767, 95% CI: 0.611-0.963, P =0.022). Moreover, the pooled data showed a significant association between the PAI-1 4G/5G polymorphism and RPL risk under all five models i.e., allele (OR = 2.352, 95% CI: 1.623-3.408, P ≤0.001), heterozygote (OR = 8.364, 95% CI: 4.744-14.756, P ≤0.001), homozygote (OR = 2.192, 95% CI: 1.093-4.394, P =0.027), dominant (OR = 2.354, 95% CI: 1.309-4.235, P =0.004), and recessive (OR = 5.208, 95% CI: 3.005-9.025, P ≤0.001). Stratification analysis revealed that these polymorphisms were associated with RPL risk by number of miscarriage. Conclusions: Our pooled data indicated that ACE I/D and PAI-1 4G/5G polymorphisms are significantly associated with an increased risk of RPL in Iranian women. These significant findings brought us to the decision that the investigation might be adequate for ACE I/D and PAI-1 4G/5G polymorphisms in the Iranian population. Keywords: Pregnancy Loss, Miscarriage, Thrombophilia, Plasminogen Activator Inhibitor-1, Angiotensin I Converting Enzyme, Polymorphism
Seyed Alireza Dastgheib, Mojgan Karimi-Zarchi, Reza Bahrami, Razie Sadat Tabatabaei, Atiyeh Javaheri, Mahmood Noorishadkam, Seyed Reza Mirjalili, Hossein Neamatzadeh. A Meta-Analysis for Association of ACE I/D and PAI-1 4G/5G Polymorphisms with Recurrent Pregnancy Loss in Iranian Women: are the investigations adequate?. . 2021; 18(2): 0-0
Corresponding Author: Reza Bahrami, Iran |
|